Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irrisept in Primary Shoulder Arthroplasty
NCT03938467Phase 4Completed
- Sponsor
- Orthopaedic Associates of Michigan
- Start
- Mar 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Irrisept in Cutibacterium acnes infection, sponsored by Orthopaedic Associates of Michigan. Started Mar 2021; status: completed.
02
Drugs
Irrisept
03
Conditions
Cutibacterium acnes infection
Beyond the preview
Go deeper on NCT03938467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03938467.